Jaakkola, Tiina <br/><br/>
Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors.  [electronic resource] 

 -  Basic & clinical pharmacology & toxicology  Jul 2006 
 - 44-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1742-7835 
<br/><br/><label>Standard No.: </label>10.1111/j.1742-7843.2006.pto_437.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors<br/>Cytochrome P-450 CYP2C8<br/>Cytochrome P-450 CYP3A<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Drug Interactions<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Hypoglycemic Agents--pharmacokinetics<br/>In Vitro Techniques<br/>Microsomes, Liver--drug effects<br/>NADP--metabolism<br/>Pioglitazone<br/>Thiazolidinediones--pharmacokinetics